Information about the three-dimensional structure of MW1 and its interactions with mutant huntingtin could assist in the development of polyQ length-based methods for quantitation of huntingtin in patients with HD in clinical trials (Zuccato et al., 2010 ▸). Here, HTT is linked to Huntington disease.